We are live on ! Find out more
FHTX icon

Foghorn Therapeutics
FHTX

72 hedge funds and large institutions have $227M invested in Foghorn Therapeutics in 2024 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 23 increasing their positions, 16 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

240% more call options, than puts

Call options by funds: $34K | Put options by funds: $10K

44% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 16

28% more capital invested

Capital invested by funds: $177M → $227M (+$49.4M)

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

9.13% more ownership

Funds ownership: 62.16% → 71.29% (+9.1%)

4% more funds holding

Funds holding: 69 → 72 (+3)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
72
Holders Change
+3
Holders Change %
+4.35%
% of All Funds
1.04%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
16
Increased
23
Reduced
16
Closed
13
Calls
$34K
Puts
$10K
Net Calls
+$24K
Net Calls Change
-$17K

Top Buyers

1
BI
BVF Inc
California
+$31.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$22M
3
DM
Deerfield Management
New York
+$15M
4
PA
Perceptive Advisors
New York
+$3.24M
5
DCM
Driehaus Capital Management
Illinois
+$1.72M

Top Sellers

1
Invesco
Invesco
Georgia
-$376K
2
Vanguard Group
Vanguard Group
Pennsylvania
-$256K
3
Marshall Wace
Marshall Wace
United Kingdom
-$245K
4
Millennium Management
Millennium Management
New York
-$239K
5
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$190K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$374K -$58.8K -9,872 -13%
Citadel Advisors
27
Citadel Advisors
Florida
$373K +$243K +40,877 +171%
BCM
28
Bridgeway Capital Management
Texas
$331K +$342K +57,500 New
BBA
29
Baker Bros. Advisors
New York
$259K – – –
Wellington Management Group
30
Wellington Management Group
Massachusetts
$252K +$261K +43,789 New
Acadian Asset Management
31
Acadian Asset Management
Massachusetts
$243K – – –
DCM
32
DAFNA Capital Management
California
$241K +$249K +41,850 New
ETC
33
Exchange Traded Concepts
Oklahoma
$207K -$66.6K -11,176 -24%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$206K +$54.6K +9,171 +34%
Jane Street
35
Jane Street
New York
$196K +$203K +34,127 New
AWA
36
Alta Wealth Advisors
Massachusetts
$173K – – –
Bank of America
37
Bank of America
North Carolina
$155K +$84.5K +14,179 +111%
D.E. Shaw & Co
38
D.E. Shaw & Co
New York
$148K +$153K +25,738 New
CIC
39
Cornercap Investment Counsel
Georgia
$147K -$1.5K -252 -1%
CC
40
Corton Capital
Ontario, Canada
$139K +$144K +24,207 New
Millennium Management
41
Millennium Management
New York
$126K -$239K -40,093 -65%
Walleye Capital
42
Walleye Capital
New York
$98.6K +$102K +17,145 New
HSBC Holdings
43
HSBC Holdings
United Kingdom
$89.2K +$465 +78 +0.5%
Goldman Sachs
44
Goldman Sachs
New York
$87.4K +$22.5K +3,773 +33%
AllianceBernstein
45
AllianceBernstein
Tennessee
$83.9K +$27K +4,540 +45%
Barclays
46
Barclays
United Kingdom
$78.7K -$33.1K -5,550 -29%
CF
47
Corebridge Financial
Texas
$78.1K +$80.9K +13,587 New
Manulife (Manufacturers Life Insurance)
48
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$64.4K +$66.7K +11,200 New
JP Morgan Chase
49
JP Morgan Chase
New York
$63.6K -$17.8K -2,985 -21%
FT
50
Fiduciary Trust
Massachusetts
$62.6K – – –
1
2
3 4

FHTX Hedge Fund Activity: Q2 2024 in Review

72 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Foghorn Therapeutics (FHTX) for Q2 2024, worth a combined $227M — up 28% from $177M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new FHTX positions and 13 closed out — a net gain of 3 holders — while 23 added to existing stakes and 16 trimmed.

The largest buyer was BVF Inc, opening a new position worth an estimated $31.6M. The largest seller was Invesco, exiting entirely with an estimated $376K sold.

  • 72 institutional investors held Foghorn Therapeutics (FHTX) as of Q2 2024, up from 69 in Q1 2024.
  • Funds reported $227M of Foghorn Therapeutics stock for Q2 2024, up 28% quarter-over-quarter.
  • 16 funds opened new Foghorn Therapeutics positions in Q2 2024 and 13 closed out, a net change of +3 holders.
  • The largest Foghorn Therapeutics buyer in Q2 2024 was BVF Inc, an estimated $31.6M added.
  • The largest Foghorn Therapeutics seller in Q2 2024 was Invesco, an estimated $376K sold.

Based on aggregated 13F filings for Q2 2024.